http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106172371-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0221 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate | 2016-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106172371-B |
| titleOfInvention | A kind of compound Cardioprotective liquid |
| abstract | The present invention provides a kind of compound Cardioprotective liquid.The compound Cardioprotective liquid is the mixture that Kaempferol, astragalin, liquorice chalcone B, liquorice chalcone C or dihydromyricetin and HTK liquid are formed.The present invention provides a kind of preferred embodiment of compound Cardioprotective liquid, i.e., the described compound Cardioprotective liquid is dihydromyricetin or astragalin and the mixture that HTK liquid is formed.Novel compound Cardioprotective liquid of the invention can not only prevent cardiac muscle cell apoptosis, moreover it is possible to reduce the edema as caused by cryo-conservation, improve the in vitro heart cooling jet flow holding time, prevent the damage of oxygen radical. |
| priorityDate | 2016-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.